Global Non-mercury Sphygmomanometer Market Strategic Research Report

Scope of the Report

The global Non-mercury Sphygmomanometer market size is predicted to grow from US$ 1,277 million in 2025 to US$ 1,960 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

A non-mercury sphygmomanometer is a blood pressure measurement device designed to replace traditional mercury column sphygmomanometers, using aneroid (mechanical dial) or electronic/digital sensing technologies to measure systolic and diastolic blood pressure without the environmental and health risks associated with mercury.

From an industry chain perspective, the upstream segment includes suppliers of key components and materials such as pressure sensors or mechanical capsules (for aneroid types), electronic pressure transducers and PCBs (for digital types), rubber or silicone inflation bulbs, air valves, cuffs and bladders (nylon, polyester fabrics, TPU/PVC), LCD displays, batteries, and plastic or metal housings, as well as calibration and testing equipment. The midstream segment consists of medical device manufacturers and assemblers that design, assemble, calibrate, and certify non-mercury sphygmomanometers, offering products such as manual aneroid devices for clinical use, semi-automatic devices, and fully automatic digital upper-arm or wrist monitors, often complying with international standards (e.g., ISO, AAMI, ESH) and regulatory requirements. The downstream segment includes distribution and end-use channels, such as medical equipment distributors, hospital procurement systems, pharmacies, e-commerce platforms, and government or public health tenders, with end users spanning hospitals, clinics, primary healthcare centers, pharmacies, and home healthcare consumers. In terms of applications and market dynamics, non-mercury sphygmomanometers are increasingly adopted due to global mercury-elimination policies, improved accuracy and ease of use, portability, and growing demand for home blood pressure monitoring, making them a core product category within the broader cardiovascular diagnostics and patient monitoring market.

In 2025, global Non-mercury Sphygmomanometer sales volume reached approximately 11 million units, with an average global market price of around US$ 115 per unit.

Global key Non-mercury Sphygmomanometer players cover A&D Medical, Jitron, Microlife, BOKANG, INDOSurgicals, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-mercury Sphygmomanometer market?

What factors are driving Non-mercury Sphygmomanometer market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-mercury Sphygmomanometer market opportunities vary by end market size?

How does Non-mercury Sphygmomanometer break out by Type, by Application?

This report presents a comprehensive overview of the global Non-mercury Sphygmomanometer market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Desktop
• Portable
• Other

Segment by Technology

• Aneroid (Mechanical Dial)
• Digital (Electronic/Oscillometric)

Segment by Application

• Hospitals
• Clinics
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Non-mercury Sphygmomanometer market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Clinics, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact